- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
AJMC® in the Press, January 26, 2024
Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
An article from mHealthIntelligence referenced a study published in the January 2024 issue of The American Journal of Managed Care® (AJMC®). The study, “Characterizing Telehealth Use in the US: Analysis of the 2022 Health Information National Trends Survey,” concluded that discussing the motivation of patients to use telehealth could help policy makers and administrators to maximize health care access and quality.
An article from Good Men Project referenced an article published in the April 2021 issue of AJMC. The piece, “Enhance Care Continuity Post COVID-19,” argued that the pandemic had created an opportunity to augment continuity to improve patient-centered outcomes and improve spending efficiency.
An article from Biospace referenced an article published on AJMC.com, the website of AJMC. The article, “Analysis Explores Gene Therapy’s Potential to Be Cost-Effective in SCD,” reported gene therapy in the treatment of sickle cell disease could be cost effective if it was priced below the $2 million mark.
PAH Treatment Outcomes Similar Regardless of Diagnosis Time
November 1st 2024The study findings underscore the importance of early initiation of macitentan and tadalafil among patients who have pulmonary arterial hypertension (PAH), and represent a shift in understanding of prognosis based on diagnosis timing.
Read More
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
